HBIO Q1 2026 Earnings EPS Surprises to the Upside Despite Challenging Quarter SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline OXLCN Q4 2025 Earnings EPS Misses Estimates Amid Stable Preferred Distribution PRK Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Giftify Inc GIFT Q1 2026 Earnings Narrow EPS Beat Amid Revenue Silence